Osteoinductive Molecules in Orthopaedics: Basic Science and Preclinical Studies
暂无分享,去创建一个
S. T. Yoon | S. Boden | S. Yoon | S. D. Boden | S. Tim Yoon
[1] W. Hutton,et al. Adenoviral Delivery of LIM Mineralization Protein-1 Induces New-Bone Formation in Vitro and in Vivo , 2001, The Journal of bone and joint surgery. American volume.
[2] L. Titus,et al. Gene therapy for spine fusion. , 2000, Clinical orthopaedics and related research.
[3] Linshu Liu,et al. Inductive activity of recombinant human growth and differentiation factor-5. , 2000, Biochemical Society transactions.
[4] M. Ito,et al. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. , 2000, The Journal of clinical investigation.
[5] K. Miyazono,et al. Positive and negative regulation of TGF-beta signaling. , 2000, Journal of cell science.
[6] A. Linde,et al. Effects of recombinant human fibroblast growth factor-2 on osteogenic cell populations during orthopic osteogenesis in vivo. , 2000, Bone.
[7] J. Heckman,et al. Bone morphogenetic protein but not transforming growth factor-beta enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer. , 1999, The Journal of bone and joint surgery. American volume.
[8] L. Titus,et al. Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion. , 1999, Spine.
[9] R. F. Morgan,et al. Repair of a Rodent Nasal Critical‐Size Osseous Defect With Osteoblast Augmented Collagen Gel , 1999, The Laryngoscope.
[10] J. Andrades,et al. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells. , 1999, Experimental cell research.
[11] J. Poser,et al. Novel formulation of fibroblast growth factor‐2 in a hyaluronan gel accelerates fracture healing in nonhuman primates , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[12] A Daluiski,et al. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. , 1999, The Journal of bone and joint surgery. American volume.
[13] S. Boden,et al. Posterolateral Lumbar Intertransverse Process Spine Arthrodesis With Recombinant Human Bone Morphogenetic Protein 2/Hydroxyapatite‐Tricalcium Phosphate After Laminectomy in the Nonhuman Primate , 1999, Spine.
[14] J. Fischgrund,et al. The Use of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP‐2) to Promote Spinal Fusion in a Nonhuman Primate Anterior Interbody Fusion Model , 1999, Spine.
[15] L. Titus,et al. New formulations of demineralized bone matrix as a more effective graft alternative in experimental posterolateral lumbar spine arthrodesis. , 1999, Spine.
[16] B. Cunningham,et al. Osteogenic protein versus autologous interbody arthrodesis in the sheep thoracic spine. A comparative endoscopic study using the Bagby and Kuslich interbody fusion device. , 1999, Spine.
[17] W. Hutton,et al. The use of coralline hydroxyapatite with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion. , 1999, Spine.
[18] J. Lou,et al. Gene therapy: Adenovirus‐mediated human bone morphogenetic protein‐2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[19] M. Matzuk,et al. The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. , 1998, Molecular endocrinology.
[20] D. Hu,et al. LMP-1, a LIM-domain protein, mediates BMP-6 effects on bone formation. , 1998, Endocrinology.
[21] L. Titus,et al. 1998 Volvo Award Winner in Basic Science Studies: Lumbar Spine Fusion by Local Gene Therapy With a cDNA Encoding a Novel Osteoinductive Protein (LMP‐1) , 1998, Spine.
[22] M. Maeda,et al. Continuous Administration of Basic Fibroblast Growth Factor (FGF-2) Accelerates Bone Induction on Rat Calvaria— An Application of a New Drug Delivery System , 1998, Journal of dental research.
[23] L. Titus,et al. Gene expression during autograft lumbar spine fusion and the effect of bone morphogenetic protein 2 , 1998 .
[24] E. Canalis,et al. Insulin-like growth factor II promoter expression in cultured rodent osteoblasts and adult rat bone. , 1998, Endocrinology.
[25] G. Finerman,et al. Regional gene therapy with a BMP‐2‐producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[26] M. Markel,et al. Cervical Interbody Fusion Cages: An Animal Model With and Without Bone Morphogenetic Protein , 1998, Spine.
[27] H. Tesluk,et al. Effect of insulin-like growth factor type I on critical size calvarial bone defects in irradiated rats. , 1998, The Journal of craniofacial surgery.
[28] D. Silcox,et al. Reversing the Inhibitory Effect of Nicotine on Spinal Fusion Using an Osteoinductive Protein Extract , 1998, Spine.
[29] S. Boden,et al. Experimental Posterolateral Lumbar Spinal Fusion With a Demineralized Bone Matrix Gel , 1998, Spine.
[30] S. Boden,et al. Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. , 1997, Journal of spinal disorders.
[31] A. Patwardhan,et al. Tibial segmental defect repair: Chondrogenesis and biomechanical strength modulated by basic fibroblast growth factor , 1997, The Anatomical record.
[32] S. Harris,et al. Bone Morphogenetic Protein 2 (BMP-2) Enhances BMP-3, BMP-4, and Bone Cell Differentiation Marker Gene Expression During the Induction of Mineralized Bone Matrix Formation in Culturesof Fetal Rat Calvarial Osteoblasts , 1997, Calcified Tissue International.
[33] S. Mohan,et al. Osteogenic Protein-1 Stimulates mRNA Levels of BMP-6 and Decreases mRNA Levels of BMP-2 and -4 in Human Osteosarcoma Cells , 1997, Calcified Tissue International.
[34] S. Boden,et al. Video‐Assisted Lateral Intertransverse Process Arthrodesis: Validation of a New Minimally Invasive Lumbar Spinal Fusion Technique in the Rabbit and Nonhuman Primate (Rhesus) Models , 1996, Spine.
[35] R. Delamarter,et al. Effective Doses of Recombinant Human Bone Morphogenetic Protein‐2 in Experimental Spinal Fusion , 1996, Spine.
[36] W. Hutton,et al. Morphology of the lumbar intertransverse process fusion mass in the rabbit model: a comparison between two bone graft materials--rhBMP-2 and autograft. , 1996, Journal of spinal disorders.
[37] K. Lyons,et al. Bone morphogenetic protein-2: biology and applications. , 1996, Clinical orthopaedics and related research.
[38] J. Michael Kabo,et al. Evaluation of rhBMP‐2 With an OPLA Carrier in a Canine Posterolateral (Transverse Process) Spinal Fusion Model , 1995, Spine.
[39] W. Hutton,et al. Experimental Spinal Fusion With Recombinant Human Bone Morphogenetic Protein‐2 , 1995, Spine.
[40] H. Tesluk,et al. Effect of Insulin‐Like Growth Factor Type 1 on Critical‐Size Defects in Diabetic Rats , 1995, The Journal of craniofacial surgery.
[41] S. Cook,et al. In Vivo Evaluation of Recombinant Human Osteogenic Protein (rhOP-1) Implants As a Bone Graft Substitute for Spinal Fusions , 1994, Spine.
[42] N. Copeland,et al. Limb alterations in brachypodism mice due to mutations in a new member of the TGFβ-superfamily , 1994, Nature.
[43] S. Frenkel,et al. Demineralized Bone Matrix: Enhancement of Spinal Fusion , 1993, Spine.
[44] V. Rosen,et al. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. , 1992, The Journal of bone and joint surgery. American volume.
[45] T. Lindholm,et al. Interaction of allogeneic demineralized bone matrix and porous hydroxyapatite bioceramics in lumbar interbody fusion in rabbits. , 1991, Clinical orthopaedics and related research.
[46] E. Wang,et al. Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. , 1991, Archives of otolaryngology--head & neck surgery.
[47] M. Urist,et al. Augmentation of spinal fusion with bone morphogenetic protein in dogs. , 1989, Clinical orthopaedics and related research.
[48] T S Lindholm,et al. Response of bone marrow stroma cells to demineralized cortical bone matrix in experimental spinal fusion in rabbits. , 1988, Clinical orthopaedics and related research.
[49] M. Urist,et al. Bone cell differentiation and growth factors. , 1983, Science.
[50] K. Takagi,et al. The role of bone marrow in bone morphogenetic protein-induced repair of femoral massive diaphyseal defects. , 1982, Clinical orthopaedics and related research.
[51] M. Urist,et al. Bone: Formation by Autoinduction , 1965, Science.
[52] W. Bristow. Arthrodesis , 1927, British medical journal.
[53] D. Kallmes,et al. Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy. , 1999, Journal of neurosurgery.
[54] B. Hogan,et al. Mice lacking Bmp6 function. , 1998, Developmental genetics.
[55] V. Rosen,et al. Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. , 1996, Growth factors.
[56] R. Balling,et al. Analysis of limb patterning in BMP-7-deficient mice. , 1996, Developmental genetics.